Medindia

X

Martek to Announce First Quarter 2010 Results

Wednesday, February 17, 2010 Press Release J E 4
Advertisement


COLUMBIA, Md., Feb. 16 Martek Biosciences Corporation (Nasdaq: MATK) announced today that it intends to release the results of its first quarter of fiscal 2010 on March 2, 2010, at approximately 4:00 p.m. Eastern Time (ET). At 4:45 p.m. ET Martek will conduct a conference call to discuss these results with investors. All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com.

An archived webcast of the conference call will be available on the Martek's website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 or 402-977-9140 and entering pass code 21460047.

Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA, a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life'sARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com .

Contact: Kyle Stults Investor Relations (410) 740-0081 Cassie France-Kelly Public Relations (410) 740-0081

SOURCE Martek Biosciences Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cardiome Pharma Corp. Announces US$25 Million Adva...
S
Amicus Therapeutics Announces Fourth Quarter and F...